Vaginal pessary market seen reaching $0.65 billion by 2030

The vaginal pessary market is projected to grow from $0.42 billion in 2025 to $0.65 billion by 2030, driven by rising demand for non-surgical pelvic health treatments and telemedicine adoption. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Vaginal pessaries offer a non-surgical option for pelvic organ prolapse and stress urinary incontinence. - Market growth points to stronger demand for conservative women’s health treatments and outpatient care. - Rising telemedicine use could make fitting, follow-up and maintenance easier for more patients.

What happened: - The Business Research Company released its Vaginal Pessary Market Report 2026 covering market size, trends and a global forecast for 2026-2035. - The vaginal pessary market is estimated at $0.42 billion in 2025 and $0.46 billion in 2026. - The market is forecast to reach $0.65 billion by 2030. - The report says the market is advancing on steady demand for non-invasive urogynecological treatment options.

The details: - A vaginal pessary is typically made from silicone or plastic. - The device is inserted into the vagina to support the bladder, uterus or rectum. - It helps reposition weakened tissues and manage pelvic organ prolapse and stress urinary incontinence. - Historical growth has been supported by higher prolapse incidence, more awareness of conservative treatment options, expanded gynecological care, better medical-grade materials and improved diagnosis rates. - Forecast growth is tied to an aging female population, outpatient gynecology expansion, a stronger focus on quality-of-life treatments and broader adoption in emerging markets. - Anticipated product trends include more silicone-based pessaries, customized designs, long-term pelvic support devices and greater emphasis on comfort and safety. - The report says telemedicine can support education, follow-up care, fitting guidance, discomfort management and device maintenance. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company offers market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables in its 2026 reports. - The report includes key technologies and future trend analysis.

Between the lines: - Telemedicine is becoming a growth lever because it lowers friction for follow-up care in a treatment area that often needs repeat support. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific. - The market’s projected pace also reflects continued preference for less invasive care over surgery when appropriate. - ScienceSoft USA Corporation projects telemedicine will account for about 25% to 30% of all medical visits in the U.S. by the end of 2026.

What's next: - The report expects continued growth through 2030 as non-surgical pelvic health treatments gain wider use. - Adoption should expand as outpatient services, remote care and customized device options spread across more markets. - More product development is likely around patient comfort, safety and long-term support.